# Dexamethasone

## Dexamethasone inj 5mg/1mL

| 藥物代碼 | IDEXA |
| :--- | :--- |
| 適應症 | Conditions where the anti-inflammatory & immunosuppressive effects of the corticosteroids are desirable, especially for intensive treatment during shorter periods. |
| 副作用 | Fluid & electrolyte disturbances. CV, musculoskeletal, GI, dermatologic, neurologic, endocrine, ophth & metabolic effects. Thromboembolism, psychic disturbances. Joint tissue damage \(frequent IA inj\).Cardiovascular: HypertensionDermatologic: Atrophic condition of skin, Finding of skin healing, ImpairedEndocrine metabolic: Cushing's syndrome, Decreased body growthGastrointestinal: Disorder of gastrointestinal tractImmunologic: At risk for infectionMusculoskeletal: OsteoporosisOphthalmic: Cataract \(4% \), Raised intraocular pressure \(25% \)Psychiatric: Depression, EuphoriaRespiratory: Pulmonary tuberculosis |
| 禁忌 | Systemic fungal infection, hypersensitivity. Administration of live virus vaccine, unstable or infected joint, diagnosed sepsis. |
| 藥物保存方式 | N/A |
| 用法用量 | Cerebral edema Oral 2 mg bid-tid. Inj usual initial dose: 10 mg IV followed by 4 mg IM every 6 hr. Adrenogenital syndrome Oral 0.5-1.5 mg daily. Shock 2-6 mg/kg IV repeated in 2-6 hr if shock persists. Neonatal respiratory distress syndrome, antenatal prophylaxis 5 mg IM to mother 12 hrly. Max 4 doses. Administer 1-7days before estimated delivery. Dual therapy Day1: 4-8 mg IM; Day 2-3: 1 mg orally bid; Day 4-5: 0.5 mg orally bid; Day 6-7: 0.5 mg orally qd. Intra-articular, intralesional & soft tissue inj 0.4-6 mg. Chronic, non-fatal disease 0.5-1 mg daily. Congenital adrenal hyperplasia 0.5-1.5 mg daily. Acute, non-threatening disease 2-4.5 mg daily. Acute life-threatening disease 4-10 mg daily. Massive therapy 10-15 mg daily. |
| 肝功能異常 | 無需調整劑量  需調整劑量 |
| 腎功能異常 | 無需調整劑量  需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | Compatible - maternal benefit &gt;&gt; embryo-fetal risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | ID, IM, INS, IRR, IS, IVD, IVI, IVP, IVPUSH, LI, SCI, SUBCI |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | 【D5W】 可選  【N/S】 可選 |
| IVP 用法建議 | 靜脈推注需大於一分鐘 |
| IVD 用法建議 | Consider further dilution and administration by IV intermittent infusion over 5 to 15 minutes. \(UpToDate\) |
| 注意事項 | 一日總投與量不可超過80mg;用於皮內通常將之用生理食鹽水稀釋5倍後取約0.1mL;點眼通常稀釋25倍後來使用 Adult: May administer 4 mg/mL or 10 mg/mL concentration undiluted over &gt;1 minute. \(UpToDate\) |

## Dorison 4mg

| 藥物代碼 | ODOR4 |
| :--- | :--- |
| 適應症 | 腎皮質機能萎縮症、急性風濕性關節炎、膠原病、急性過敏病、皮膚疾患 |
| 副作用 | Common■Cardiovascular: Hypertension■Dermatologic: Atrophic condition of skin, Finding of skin healing, Impaired■Endocrine metabolic: Cushing's syndrome, Decreased body growth■Immunologic: At risk for infection■Ophthalmic: Cataract \(5% \), Raised intraocular pressure \(25% \)■Psychiatric: Depression, Euphoria■Respiratory: Pulmonary tuberculosisSerious■Cardiovascular: Cardiomyopathy■Endocrine metabolic: Hyperglycemia, Primary adrenocortical insufficiency■Gastrointestinal: Pancreatitis■Musculoskeletal: Osteoporosis■Ophthalmic: Conjunctival hemorrhage \(22% \), Glaucoma |
| 禁忌 | ■concomitant use of more than a single dose of dexamethasone with rilpivirine.■fungal infection, systemic \(oral\).■hypersensitivity to dexamethasone or any other component of the product. |
| 藥物保存方式 | 室溫 |
| 用法用量 | Tab 0.5-10 mg daily. |
| 肝功能異常 | 無需調整劑量 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 除非治療上需要 |
| 孕期用藥建議 | Compatible - maternal benefit &gt;&gt; embryo-fetal risk |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | No \(Limited\) Human Data - Probably Compatible 無\(很少\)資料 - 可使用 |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

